WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 5'5001 Infant (under 12 months) mortality rate: 12
GDP / capita (US$): 13'4821 Child (under 5 years) mortality rate: 12

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 8'851  8'893  8'938  8'983  9'024  9'463  9'518  8'908 
Births 90  91  91  92  92  121  142  162 
Surviving infants 90  90  90  91  91  119  139  156 
Pop. less than 5 years 451  453  456  460  465  620  732  780 
Pop. less than 15 years 1'443  1'466  1'489  1'513  1'537  1'960  2'263  2'200 
Female 15-49 years 2'037  2'052  2'067  2'082  2'095  2'301  2'312  2'252 

Number of reported cases

(Click for retrospective incidence data for Serbia)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  383  37  370  38  4'978  37'441 
Mumps
ChartChart
  41  63  64  584  63  1'215 
Pertussis
ChartChart
  89  281  39  51  25  24  1'440  6'710 
Polio*
ChartChart
 
Rubella
ChartChart
  10  11  14  14  2'188 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  17 
Tetanus (total)**
ChartChart
  24  57  99 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Serbia)
Vaccine year result method % card seen                                                
BCG 2013  98  MICS   87  98  98  97  98  99  99* 
DTP1 2013  93  MICS   87  98 
DTP3 2013  89  MICS   87  95  93  95  91  94  95 
DTP4          88  88 
IPV1         
HepB_BD         
HepB3 2013  93  MICS   87  94  92  91  97  94 
Hib3 2013  83  MICS   87  95  94  92  90  93 
JapEnc         
MCV1          87  86  92  87  93  89 
MCV2          87  91  82  90  90 
PCV1         
PCV3         
Pol3 2013  88  MICS   87  95  93  97  93  94  98 
Rota1         
RotaC         
RCV1          87  86  93 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Serbia)
BCG
ChartChart
  98  98  97  98  99  85 
DTP1
ChartChart
  98  97  98  97  98  97 
DTP3
ChartChart
  95  93  95  91  94  95 
HepB3
ChartChart
  94  92  91  97  94 
HepB_BD
ChartChart
  99  99  99  99  99 
Hib3
ChartChart
  95  94  92  90  93 
IPV1
ChartChart
 
MCV1
ChartChart
  86  86  92  87  93  89 
MCV2
ChartChart
  86  91  82  90  90  78 
PCV3
ChartChart
 
Pol3
ChartChart
  95  93  97  93  94  98 
RCV1
ChartChart
  86  86  92  87  93  89 
RotaC
ChartChart
 

Number of districts in the country 25  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 88
From 80 to 89% 12
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7 years; Yes
DTPHibIPV 8, 14, 20 weeks; 18 months; Yes
HepB_Adult Yes special risk group
HepB_Pediatric birth; 4 weeks; 5 months; Yes
IPV Yes adults over 65 years and chronic diseases patients
Influenza_Adult >= 65 years; Yes chronic illness, pregnant women, health care workers Haj and travelers
Influenza_Pediatric >= 6 months; Yes and children with chronic illness
MMR 12 months; 7 years; Yes
MenAC Yes some chronic diseases patients, travelers
OPV 8, 14, 20 weeks; 18 months; 7, 14 years; Yes
Pneumo_conj Yes some chronic diseases patients
Pneumo_ps Yes some chronic diseases patients
Td 14 years; Yes
Typhoid Yes travelers
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No          Yes 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 25            25 

System performance

Total Nº districts in country number 25  25  25  25  25  25  25 
Nº districts with DTP3 coverage >=80% number 25    25  25  25  25  25 
% of districts with DTP3 coverage >=80% From 0 to 100% 100    100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number   16  13  22  16  22 
% of districts with MCV1 coverage >=95% From 0 to 100% 20    64  52  88  64  88 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No           

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.